For more details on the courses, please refer to the Course Catalog
| Code | Course Title | Credit | Learning Time | Division | Degree | Grade | Note | Language | Availability |
|---|---|---|---|---|---|---|---|---|---|
| PHR5274 | Advanced Regulatory Immunology | 3 | 6 | Major | Master/Doctor | Pharmacy | - | No | |
| This course introduces the latest immune regulatory mechanisms such as Regulatory T cell, Regulatory B cell, Immune check point. In addition, it will introduce the autoimmune diseases caused by their abnormal regulation and the development of immunomodulators for the immune diseases. | |||||||||
| PHR5279 | Data Analytics for Organo-Pharmacognosy 2 | 3 | 6 | Major | Master/Doctor | Pharmacy | - | No | |
| This course focus on data analysis information of the organic chemistry/synthetic compounds and pharmacognosy/natural products, and its applications in drug discovery. This course will also study the analysis and utilization of various information generated through discovery or development of organic chemistry and natural products / biopharmaceuticals. | |||||||||
| PHR5286 | The Biology of Cancer | 3 | 6 | Major | Master/Doctor | Pharmacy | Korean | Yes | |
| Cancer accounts for more than 30% of the causes of death wolrdwide, and its types and causes vary, making it a top priority in future pharmacal research fields. As analysis techniques at the level of genes or proteins led by Single Cell RNAseq have recently become possible, early diagnosis and treatment are becoming possible depending on the type of cancer. However, the vast majority of cancers are still difficult to treat and have significant unmet medical needs. Therefore, this course aims to train future prospective pharmacal researchers with different majors to contribute to the eradication of cancer, mankind's largest disease, by analyzing and understanding cancer in various ways, including molecular biology and pathophysiology. Students who have completed this course may acquire basic knowledge of all fields of tumor biology for cancer prevention and treatment, etc., and cultivate their ability to utilize it for the research of each detailed major. Specifically, in this course, we will learn a wide range of cancer characteristics, differences from normal cells, causes of cancer, pathophysiological mechanisms in the carcinogenesis process, functions of tumor genes and carcinogenic genes, history of anticancer drugs, cancer treatment and prevention strategies. | |||||||||
| PHR5287 | Synthetic Biology | 3 | 6 | Major | Master/Doctor | Pharmacy | - | No | |
| Synthetic biology is a multidisciplinary research area to build (or create) novel biological system to produce medically important materials. This course will cover key subjects for synthetic biology including (1) introduction of synthetic biology, (2) recent development in related technologies, (3) designing new pathways (or circuit) to produce materials of interest in a vehicle organisms. During the course, students will be involved in self-problem solving projects, and also student will have 1~3 chance to taking lecturers by invited speakers who are working professionals in the field of research. To encourage students, the course will also provide 1~2 flipped classes during this semester. | |||||||||
| PHR5288 | Pharmaceutical industry and Intellectual Property management | 1 | 2 | Major | Master/Doctor | Pharmacy | Korean | Yes | |
| ntellectual property management and strategy in the pharmaceutical/bio industry are becoming increasingly important. The goal of intellectual property rights management is to quickly identify the value of intellectual property rights using all available legal means, such as patent rights, trade secrets, copyrights, trademark rights, and contract law, and to maximize their value by strategically protecting them. This course covers the concept of intellectual property rights (patents, trade secrets, copyrights and trademarks) centered on patents in the process of drug R&D and product development, prior art search, the application and registration process. Based on this, the procedure for filing an Invention Disclosure Form, procedures for maintaining trade secret confidentiality and proprietary information will be covered. This lecture consists of introduction of core theory and lecture and practice on intellectual property rights. | |||||||||
| PHR5289 | Advanced Pharmaceutical Chemistry | 3 | 6 | Major | Master/Doctor | 1-4 | Pharmacy | English | Yes |
| Provides the core basic knowledge of organic chemistry necessary for graduate programs, introduces the latest research results, and discusses them together. Through this, it bridges the gap between the undergraduate curriculum and graduate studies, and especially helps graduate freshmen adapt to the graduate program. | |||||||||
| PHR5292 | Advanced Toxicology | 3 | 6 | Major | Master/Doctor | Pharmacy | Korean | Yes | |
| This course is designed to provide students with specialized knowledge on the types, causes, and mechanisms of toxic effects of toxicants on living organisms. The goal of this program is to enable master's and doctoral students in pharmacy to learn about toxicology and acquire expertise in toxicological evaluation required in the drug development process after graduation. | |||||||||
| SAI5004 | Introduction to Transdisciplinary Research | 3 | 6 | Major | Master/Doctor | 1-4 | Korean | Yes | |
| Biomedical Science is rapidly developing through the convergence of various fields of basic sciences, clinical practice as well as applied science. Especially, the convergence research on health technology and biomedical sector(including the biomedical engineering and digital healthcare sector) is the critical factor for development of biomedical science as well as medical advancement. Thus, this course covers the concept of transdisciplinary studies and its history. This course will cover the context of transdisciplinary study and problem-focused convergence research methodology. Also, in order to train convergent professional who could lead the future biomedical science and healthcare industry, this course will guide the overall convergence research process including convergent research design, implementation and application to clinical practice by selecting various multidisciplinary convergent research cases of university, hospital and business sector | |||||||||